| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Profit before tax | -3.6 | -0.1 |
| Net income | -3.6 | -0.3 |
| EPS (diluted, $ a share) | $-3.53 | $-1.25 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-Q filed with the SEC, NASDAQ: CHGA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Change Agents Corporation.: key numbers
- Share price
- $0.8863Close, Nov 16
- Market cap
- $17.7M
- Shares outstanding
- 19.95MLatest SEC cover page
- Sector
- Technology
- Industry
- Services-Computer Programming ServicesSIC 7371
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Change Agents Corporation.
All →Change Agents Leadership Change
Change Agents Corporation appointed Luisa Ingargiola, the company's current Chief Strategy Officer, as its principal executive officer effective November 4, 2026. She will serve in this role until a new Chief Executive Officer is appointed and will not receive additional compensation for the service. The company also issued a $250,000 promissory note to Harllon Holdings LLC and issued 150,000 shares to consultants for services rendered.
Change Agents Capital Raise
Change Agents Corporation held a special meeting where stockholders approved several proposals related to equity financing, including the potential issuance of shares under an Equity Purchase Agreement with Hudson Global Ventures, LLC. Stockholders also approved the issuance of shares upon the conversion of promissory notes held by Vanquish Funding Group and an amendment to increase authorized common stock from 100 million to 125 million shares. These approvals were primarily sought to comply with Nasdaq Listing Rule 5635(d) regarding the issuance of 20% or more of outstanding shares.
- Counterparty
- Hudson Global Ventures, LLC
Change Agents Debt Financing Update with Dune Equity Holdings, LLC
Change Agents Corporation executed unsecured promissory notes totaling $250,000 with maturity dates of December 1, 2026. Additionally, the company entered into waivers with Dune Equity Holdings and FirstFire Global Opportunities Fund regarding prepayment provisions, issuing pre-funded warrants for 99,500 shares as consideration.
- Counterparty
- Dune Equity Holdings, LLC
- Term
- through Dec 2026
Change Agents Leadership Change
Change Agents Corporation appointed Eric Weisblum as an independent director to its board of directors, effective October 12, 2026. Mr. Weisblum, who is currently the CEO of Silo Pharma Inc, will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees.
Change Agents Leadership Change
Meng Li has resigned from her roles as Interim CEO, COO, and Secretary of Change Agents Corporation, effective October 8, 2026. Her departure is intended to facilitate the company's preparation for a potential acquisition in the drone defense industry, and the Board has initiated a search for a replacement from the global defense and AI sectors.
Change Agents Debt Financing Update with certain accredited investors
Change Agents Corporation issued $336,000 in aggregate principal amount of original issue discount promissory notes for gross proceeds of $300,000. The notes mature on April 30, 2027, and the proceeds were used to repay existing indebtedness and for general corporate purposes. As an inducement, the company also issued pre-funded warrants to purchase 100,000 shares of common stock at a nominal exercise price.
- Counterparty
- certain accredited investors
- Term
- through April 2027